S. 4302 · 117th Congress · Senate

Biologics Market Transparency Act of 2022

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Introduced
May 25, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Biologics Market Transparency Act of 2022

This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.

Action Timeline

2
  1. MAY 25, 2022•IntroReferral

    Introduced in Senate

  2. MAY 25, 2022•IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: May 25, 2022

Active